SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-013014
Filing Date
2022-04-01
Accepted
2022-04-01 09:11:51
Documents
2
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1573
2 EX-24 DOCUMENT attachment1.htm EX-24 4131
  Complete submission text file 0000899243-22-013014.txt   7088
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 303 SOUTH BROADWAY SUITE 125 TARRYTOWN NY 10591
Business Address
Derby Michael (Reporting) CIK: 0001809613 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 22796043